IKK/NF-κB/Rel in Acute Pancreatitis and Pancreatic cancer: Torments of tantalus

Hana Algül, Roland M. Schmid

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Pancreatic ductal adenocarcinoma (PDA) and severe acute pancreatitis (AP) are still unresolved problems in routine clinicalpractice. Although the biologies of these diseases are fundamentally different, both forms share the problem of high morbidity, mortality and lack of specific therapeutic options. Therapy in these diseases is mostly symptomatic or non-specific. Over the last few years a huge body of evidence has emerged supporting a fundamental role of the IKK/NF-kB/Rel signalling pathway in the pathophysiology of pancreatic ductal adenocarcinoma and acute pancreatitis. The therapeutic potential and benefit of targeting NF-κB in pancreatic disorders and the possible complications and pitfalls of such an approach, are explored in this review.

Original languageEnglish
Title of host publicationClinical Update on Inflammatory Disorders of the Gastrointestinal Tract
PublisherS. Karger AG
Pages166-175
Number of pages10
Volume26
ISBN (Electronic)9783805592956
ISBN (Print)9783805592949
DOIs
StatePublished - 12 Nov 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'IKK/NF-κB/Rel in Acute Pancreatitis and Pancreatic cancer: Torments of tantalus'. Together they form a unique fingerprint.

Cite this